or Try an Advanced Search...

    Opko Health Stocks List

    Symbol Grade Name % Change
    COCP B Cocrystal Pharma, Inc. 4.37
    OPK C OPKO Health Inc. -1.27
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Influenza Active Pharmaceutical Ingredients Alzheimer's Disease Antibiotics Antiviral Drug Asthma Autoimmune Disease Biocides Biology Biomarkers Biotechnology Cancer Cardiovascular Products Chemotherapy Chemotherapy Induced Nausea Chronic Kidney Disease Chronic Obstructive Pulmonary Disease Clinical Trial Coronavirus Diagnostic Tests

    Related ETFs - A few ETFs which own one or more of the above listed Opko Health stocks.

    Symbol Grade Name Weight
    PBE D PowerShares Dynamic Biotech & Genome 2.78
    OZEM F Roundhill GLP-1 & Weight Loss ETF 1.72
    XHS D SPDR S&P Health Care Services ETF 0.64
    QQQS C Invesco NASDAQ Future Gen 200 ETF 0.46
    ISRA A Market Vectors Israel ETF 0.22
    View all Opko Health ETFs...
    Compare ETFs
    Compare PBE to ISRA Compare PBE to QQQS Compare XHS to QQQS

        Opko Health Stocks Recent News

        Date Stock Title
        Nov 20 OPK OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference
        Nov 19 COCP COCP: Multiple Upcoming Catalysts…
        Nov 18 OPK NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo
        Nov 16 OPK Bitdeer Technologies, PBF Energy, and More Stocks See Action From Activist Investors
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Influenza Active Pharmaceutical Ingredients Alzheimer's Disease Antibiotics Antiviral Drug Asthma Autoimmune Disease Biocides Biology Biomarkers Biotechnology Cancer Cardiovascular Products Chemotherapy Chemotherapy Induced Nausea Chronic Kidney Disease Chronic Obstructive Pulmonary Disease Clinical Trial Coronavirus Diagnostic Tests
        Opko Health

        Opko Health is a diversified healthcare company that develops, manufactures, and markets diagnostic and pharmaceutical products and services. The company operates through four segments: Diagnostics, Pharmaceutical, BioReference Laboratories, and Investment. Opko Health's Diagnostics segment develops, manufactures, and markets point-of-care diagnostic products, including the 4Kscore Test, a blood test for the early detection of prostate cancer. The Pharmaceutical segment develops, manufactures, and markets pharmaceutical products, including Rayaldee, a vitamin D prohormone for the treatment of secondary hyperparathyroidism in patients with stage 3 or 4 chronic kidney disease. The BioReference Laboratories segment provides clinical laboratory testing services. The Investment segment includes investments in healthcare companies.

        Browse All Tags